Inspire Medical Systems (INSP) 10-Q2024 Q1 Quarterly report

Filed: 7 May 24, 4:07pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advanced, agreed, AHI, al, alleged, arm, Article, ASU, attention, attractive, Austrian, authoritative, baseline, Belgian, bilateral, brand, British, broader, brought, captioned, CODM, comfort, complaint, composition, conclusion, Construction, consumed, Court, dedicate, dedicated, defend, description, disadvantage, discrimination, District, divert, durability, Eli, energy, enrolled, enrollment, entertainment, equivalent, expend, fact, fall, FASB, filer, gas, German, greenhouse, guidance, harassment, hardware, Hollywood, indirect, injection, injury, jurisdiction, Kingdom, lawsuit, Lilly, LivaNova, lost, merit, MMA, notable, Nyxoah, opportunity, oral, Pension, permitted, personal, pharmaceutical, pharmacologic, pivotal, plaintiff, practice, purported, putative, recognition, reconcile, reconciliation, recruit, refine, relief, residual, retrospective, Scope, settled, speed, sporting, succeeding, successful, suggest, suite, superior, tangible, tirzepatide, Topic, trial, UPPP, venue, vigorously, weather, wrongful

Removed: accreted, airing, Australian, authorized, begun, carryforward, charge, created, deducting, Discretionary, earlier, employed, employment, enhanced, epidemic, experiencing, extremity, floor, head, IA, imaging, implantation, initial, Labour, LIBOR, list, Listing, loan, longevity, magnetic, manufacturability, mature, Ministry, MLHW, MRI, neurostimulator, nominal, October, outbreak, predicted, prepayable, prepayment, raw, recover, remote, repaid, resonance, resurgence, scan, scheduled, Therapeutic, TV, underwriting, Welfare

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated INSP transcripts

INSP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Inspire Medical Systems, Inc. (the "Company") for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date:

May 7, 2024

By:

/s/ RICHARD J. BUCHHOLZ

Richard J. Buchholz

Chief Financial Officer

(principal financial officer)

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.